Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.001 | 0.0223 | 1 |
Echinococcus multilocularis | bloom syndrome protein | 0.002 | 0.5856 | 0.4877 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.0223 | 0.0381 |
Entamoeba histolytica | recQ family DNA helicase | 0.001 | 0.0223 | 0.0381 |
Echinococcus granulosus | ATP dependent DNA helicase Q1 | 0.002 | 0.5856 | 0.4877 |
Echinococcus multilocularis | lamin | 0.0027 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.1911 | 0.1727 |
Onchocerca volvulus | 0.0027 | 1 | 0.5 | |
Schistosoma mansoni | lamin | 0.0027 | 1 | 1 |
Schistosoma mansoni | intermediate filament proteins | 0.0027 | 1 | 1 |
Brugia malayi | Bloom's syndrome protein homolog | 0.002 | 0.5856 | 0.4291 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.002 | 0.5856 | 0.5 |
Echinococcus multilocularis | ATP dependent DNA helicase Q1 | 0.002 | 0.5856 | 0.4877 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0223 | 0.0000000048454 |
Echinococcus multilocularis | musashi | 0.0027 | 1 | 1 |
Schistosoma mansoni | DNA helicase recq1 | 0.002 | 0.5856 | 0.5856 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.5856 | 0.5761 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.002 | 0.5856 | 0.5 |
Echinococcus multilocularis | lamin dm0 | 0.0027 | 1 | 1 |
Echinococcus granulosus | lamin | 0.0027 | 1 | 1 |
Loa Loa (eye worm) | RecQ helicase | 0.002 | 0.5856 | 0.5761 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 0.5856 | 0.4291 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.1625 | 0.1434 |
Echinococcus granulosus | intermediate filament protein | 0.0027 | 1 | 1 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 0.5856 | 1 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 0.5856 | 0.5 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0027 | 1 | 1 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.002 | 0.5856 | 0.5761 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.002 | 0.5856 | 0.5 |
Onchocerca volvulus | 0.0027 | 1 | 0.5 | |
Trichomonas vaginalis | DNA helicase recq, putative | 0.002 | 0.5856 | 0.5 |
Schistosoma mansoni | DNA helicase recq5 | 0.002 | 0.5856 | 0.5856 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 0.5856 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0027 | 1 | 1 |
Echinococcus granulosus | lamin dm0 | 0.0027 | 1 | 1 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.002 | 0.5856 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.9714 | 0.9707 |
Treponema pallidum | ATP-dependent DNA helicase | 0.001 | 0.0223 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.1625 | 0.1434 |
Schistosoma mansoni | lamin | 0.0027 | 1 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 0.5856 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0027 | 1 | 1 |
Plasmodium falciparum | ATP-dependent DNA helicase Q1 | 0.002 | 0.5856 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 1 | 1 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 0.5856 | 0.4291 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0014 | 0.2742 | 0.2576 |
Echinococcus granulosus | bloom syndrome protein | 0.002 | 0.5856 | 0.4877 |
Leishmania major | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 0.5856 | 0.5 |
Echinococcus granulosus | ATP dependent DNA helicase Q5 | 0.002 | 0.5856 | 0.4877 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.001 | 0.0223 | 0.0223 |
Entamoeba histolytica | recQ family helicase, putative | 0.002 | 0.5856 | 1 |
Echinococcus multilocularis | ATP dependent DNA helicase Q5 | 0.002 | 0.5856 | 0.4877 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.